BMC Research Notes (Oct 2023)

Targeted sequencing of selected functional genes in patients with wild-type transthyretin amyloidosis

  • Inmaculada Moreno-Gázquez,
  • Raquel Pérez-Palacios,
  • Lucia Abengochea-Quílez,
  • Carmen Lahuerta Pueyo,
  • Ana Roteta Unceta Barrenechea,
  • Alejandro Andrés Gracia,
  • Miguel Angel Aibar Arregui,
  • Sebastián Menao Guillén

DOI
https://doi.org/10.1186/s13104-023-06491-z
Journal volume & issue
Vol. 16, no. 1
pp. 1 – 8

Abstract

Read online

Abstract Objective Wild-type transthyretin (ATTRwt) amyloidosis is caused by the misfolding and deposition of the transthyretin protein (TTR) in the absence of mutations in the TTR gene. Studies regarding the variant form of ATTR amyloidosis (ATTRv) suggest that the presence of single-nucleotide polymorphisms (SNP) in genes other than the TTR, may influence the development of the disease. However, other genetic factors involved in the aetiopathogenesis of ATTRwt are currently unknown. This work investigates the presence of sequence variants in genes selected for their possible impact on ATTRwt amyloidosis. To do so, targeted sequencing of 84 protein-coding genes was performed in a cohort of 27 patients diagnosed with ATTRwt. Results After applying quality and frequency filtering criteria, 72 rare or novel genetic variants were found. Subsequent classification according to the ACMG-AMP criteria resulted in 17 variants classified as of uncertain significance in 14 different genes. To our knowledge, this is the first report associating novel gene variants with ATTRwt amyloidosis. In conclusion, this study provides potential insights into the aetiopathogenesis of ATTRwt amyloidosis by linking novel coding-gene variants with the occurrence of the disease.

Keywords